5-Aza-2-deoxycytidine inhibits osteolysis induced by titanium particles by regulating RANKL/OPG ratio
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 529 (3) , 629-634
Abstract
No abstract availableKeywords
Funding Information
- Harbin Medical University (HYDSYYZ201504)
This publication has 32 references indexed in Scilit:
- Age-associated epigenetic drift: implications, and a case of epigenetic thrift?Human Molecular Genetics, 2013
- Inhibiting wear particles-induced osteolysis with naringinInternational Orthopaedics, 2012
- DNA methylation contributes to the regulation of sclerostin expression in human osteocytesJournal of Bone and Mineral Research, 2011
- Denosumab for bone diseases: translating bone biology into targeted therapyEuropean Journal of Endocrinology, 2011
- Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: Differential effects of 5-aza-deoxycytidine and trichostatin ADifferentiation, 2011
- 5-Azacytidine facilitates osteogenic gene expression and differentiation of mesenchymal stem cells by alteration in DNA methylationCytotechnology, 2009
- Particle-Induced Osteolysis in Three-Dimensional Micro-Computed TomographyCalcified Tissue International, 2007
- Inhibiting wear particles-induced osteolysis with doxycyclineActa Pharmacologica Sinica, 2007
- Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapiesArthritis Research & Therapy, 2007
- Erythromycin inhibits wear debris‐induced osteoclastogenesis by modulation of murine macrophage NF‐κB activityJournal of Orthopaedic Research, 2004